The report offers detailed coverage of Angiotensin Receptor Antagonists industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Angiotensin Receptor Antagonists by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Angiotensin II receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
The report forecast global Angiotensin Receptor Antagonists market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025.
First, this report covers the present status and the future prospects of the global Angiotensin Receptor Antagonists market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
At the same time, we classify Angiotensin Receptor Antagonists according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows: By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
Key Companies
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Market by Order Type
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Market by Application
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Angiotensin Receptor Antagonists Market Size Growth Rate by Type (2020-2025)
1.3.2 Valsartan
1.3.3 Telmisartan
1.3.4 Losartan
1.3.5 Irbesartan
1.3.6 Azilsartan
1.3.7 Olmesartan
1.4 Market Segment by Application
1.4.1 Global Angiotensin Receptor Antagonists Market Share by Application (2020-2025)
1.4.2 Hypertension
1.4.3 Cardiovascular Diseases
1.4.4 Kidney Diseases
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Angiotensin Receptor Antagonists Market Size
2.1.1 Global Angiotensin Receptor Antagonists Revenue 2015-2025
2.1.2 Global Angiotensin Receptor Antagonists Sales 2015-2025
2.2 Angiotensin Receptor Antagonists Growth Rate by Regions
2.2.1 Global Angiotensin Receptor Antagonists Sales by Regions 2015-2019
2.2.2 Global Angiotensin Receptor Antagonists Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Angiotensin Receptor Antagonists Sales by Manufacturers
3.1.1 Angiotensin Receptor Antagonists Sales by Manufacturers 2015-2019
3.1.2 Angiotensin Receptor Antagonists Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Angiotensin Receptor Antagonists Revenue by Manufacturers (2015-2019)
3.2.2 Angiotensin Receptor Antagonists Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Angiotensin Receptor Antagonists Market Concentration Ratio (CR5 and HHI)
3.3 Angiotensin Receptor Antagonists Price by Manufacturers
3.4 Key Manufacturers Angiotensin Receptor Antagonists Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Angiotensin Receptor Antagonists Market
3.6 Key Manufacturers Angiotensin Receptor Antagonists Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Valsartan Sales and Revenue (2015-2019)
4.1.2 Telmisartan Sales and Revenue (2015-2019)
4.1.3 Losartan Sales and Revenue (2015-2019)
4.1.4 Irbesartan Sales and Revenue (2015-2019)
4.1.5 Azilsartan Sales and Revenue (2015-2019)
4.1.6 Olmesartan Sales and Revenue (2015-2019)
4.2 Global Angiotensin Receptor Antagonists Sales Market Share by Type
4.3 Global Angiotensin Receptor Antagonists Revenue Market Share by Type
4.4 Angiotensin Receptor Antagonists Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Angiotensin Receptor Antagonists Sales by Application
6 United States
6.1 United States Angiotensin Receptor Antagonists Breakdown Data by Company
6.2 United States Angiotensin Receptor Antagonists Breakdown Data by Type
6.3 United States Angiotensin Receptor Antagonists Breakdown Data by Application
7 European Union
7.1 European Union Angiotensin Receptor Antagonists Breakdown Data by Company
7.2 European Union Angiotensin Receptor Antagonists Breakdown Data by Type
7.3 European Union Angiotensin Receptor Antagonists Breakdown Data by Application
8 China
8.1 China Angiotensin Receptor Antagonists Breakdown Data by Company
8.2 China Angiotensin Receptor Antagonists Breakdown Data by Type
8.3 China Angiotensin Receptor Antagonists Breakdown Data by Application
9 Rest of World
9.1 Rest of World Angiotensin Receptor Antagonists Breakdown Data by Company
9.2 Rest of World Angiotensin Receptor Antagonists Breakdown Data by Type
9.3 Rest of World Angiotensin Receptor Antagonists Breakdown Data by Application
9.4 Rest of World Angiotensin Receptor Antagonists Breakdown Data by Countries
9.4.1 Rest of World Angiotensin Receptor Antagonists Sales by Countries
9.4.2 Rest of World Angiotensin Receptor Antagonists Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Angiotensin Receptor Antagonists
10.1.4 Angiotensin Receptor Antagonists Product Introduction
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Angiotensin Receptor Antagonists
10.2.4 Angiotensin Receptor Antagonists Product Introduction
10.2.5 Novartis Recent Development
10.3 Merck
10.3.1 Merck Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Angiotensin Receptor Antagonists
10.3.4 Angiotensin Receptor Antagonists Product Introduction
10.3.5 Merck Recent Development
10.4 Astra Zeneca
10.4.1 Astra Zeneca Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Angiotensin Receptor Antagonists
10.4.4 Angiotensin Receptor Antagonists Product Introduction
10.4.5 Astra Zeneca Recent Development
10.5 Jhonson and Johnson
10.5.1 Jhonson and Johnson Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Angiotensin Receptor Antagonists
10.5.4 Angiotensin Receptor Antagonists Product Introduction
10.5.5 Jhonson and Johnson Recent Development
10.6 Eli Lilly
10.6.1 Eli Lilly Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Angiotensin Receptor Antagonists
10.6.4 Angiotensin Receptor Antagonists Product Introduction
10.6.5 Eli Lilly Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Angiotensin Receptor Antagonists
10.7.4 Angiotensin Receptor Antagonists Product Introduction
10.7.5 Sanofi Recent Development
10.8 Bristol-Myers Squibb
10.8.1 Bristol-Myers Squibb Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Angiotensin Receptor Antagonists
10.8.4 Angiotensin Receptor Antagonists Product Introduction
10.8.5 Bristol-Myers Squibb Recent Development
10.9 Bayer
10.9.1 Bayer Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Angiotensin Receptor Antagonists
10.9.4 Angiotensin Receptor Antagonists Product Introduction
10.9.5 Bayer Recent Development
10.10 GSK
10.10.1 GSK Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Angiotensin Receptor Antagonists
10.10.4 Angiotensin Receptor Antagonists Product Introduction
10.10.5 GSK Recent Development
10.11 Teva Pharmaceutical
12 Market Forecast
12.1 Global Angiotensin Receptor Antagonists Sales and Revenue Forecast 2020-2025
12.2 Global Angiotensin Receptor Antagonists Sales Forecast by Type
12.3 Global Angiotensin Receptor Antagonists Sales Forecast by Application
12.4 Angiotensin Receptor Antagonists Forecast by Regions
12.4.1 Global Angiotensin Receptor Antagonists Sales Forecast by Regions 2020-2025
12.4.2 Global Angiotensin Receptor Antagonists Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Reports Insights offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Reports Insights assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Reports Insights provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
The report is pretty good as a whole. Especially, the analysis on margin and manufacturing cost is challenging to investigate in general. The team of Reports Insights provided a proper explanation to this. It helped me understand the market well, which leads to our interest in the next marketing report from Reports Insights. I would like to thank the entire team for living up to my expectations in terms of quality & value.
I am completely satisfied with the information given in the report. Report Insights is a value driven company just like us.
Privacy requested , Managing Director
Reports Insights have understood our exact need and Delivered a solution for our requirements. Our experience with them has been fantastic.
Privacy requested, President
Report of Reports Insight has given us the ability to compete with our competitors, every dollar we spend with Reports Insights is worth every penny Reports Insights have given us a robust solution.
